New Hampshire Senate Passes Bill to Reject Some FDA Restrictions on Terminal Patients
CONCORD, N.H. (May 9, 2016) – Last week, the New Hampshire Senate passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Sponsored by Rep. Frank Edelbut (R-Wilbut), House Bill 1138 (HB1138) would give terminally ill…